ITMI20031313A0 - Associazione di agenti vasoprotettori e formazioni che li contengono - Google Patents

Associazione di agenti vasoprotettori e formazioni che li contengono

Info

Publication number
ITMI20031313A0
ITMI20031313A0 IT2003MI001313A ITMI20031313A ITMI20031313A0 IT MI20031313 A0 ITMI20031313 A0 IT MI20031313A0 IT 2003MI001313 A IT2003MI001313 A IT 2003MI001313A IT MI20031313 A ITMI20031313 A IT MI20031313A IT MI20031313 A0 ITMI20031313 A0 IT MI20031313A0
Authority
IT
Italy
Prior art keywords
trainings
association
contain
vasoprotective agents
vasoprotective
Prior art date
Application number
IT2003MI001313A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT001313A priority Critical patent/ITMI20031313A1/it
Publication of ITMI20031313A0 publication Critical patent/ITMI20031313A0/it
Priority to KR1020057024537A priority patent/KR101165934B1/ko
Priority to US10/562,214 priority patent/US20090036520A1/en
Priority to CA2530660A priority patent/CA2530660C/en
Priority to BRPI0411811-1A priority patent/BRPI0411811B1/pt
Priority to EP04739969.6A priority patent/EP1638417B1/en
Priority to PL04739969T priority patent/PL1638417T3/pl
Priority to NZ544399A priority patent/NZ544399A/en
Priority to TR2019/00241T priority patent/TR201900241T4/tr
Priority to AU2004251009A priority patent/AU2004251009B2/en
Priority to JP2006515963A priority patent/JP4960087B2/ja
Priority to PT04739969T priority patent/PT1638417T/pt
Priority to SI200432457T priority patent/SI1638417T1/sl
Priority to DK04739969.6T priority patent/DK1638417T3/en
Priority to RU2005140574/13A priority patent/RU2361430C2/ru
Priority to PCT/EP2004/006507 priority patent/WO2005000041A1/en
Priority to MXPA05013625A priority patent/MXPA05013625A/es
Priority to HK06111347.1A priority patent/HK1090519B/xx
Priority to HUE04739969A priority patent/HUE042048T2/hu
Priority to ES04739969T priority patent/ES2704633T3/es
Priority to CNB2004800177716A priority patent/CN100475061C/zh
Publication of ITMI20031313A1 publication Critical patent/ITMI20031313A1/it
Priority to NO20056162A priority patent/NO330523B1/no
Priority to RU2009109089/13A priority patent/RU2489907C2/ru
Priority to US12/721,015 priority patent/US20100160427A1/en
Priority to US13/033,826 priority patent/US8206759B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT001313A 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono. ITMI20031313A1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.
CNB2004800177716A CN100475061C (zh) 2003-06-27 2004-06-17 血管保护剂的组合以及含有它们的制剂
SI200432457T SI1638417T1 (sl) 2003-06-27 2004-06-17 Kombinacije vazoprotektivnih sredstev in formulacije, ki jih vsebujejo
RU2005140574/13A RU2361430C2 (ru) 2003-06-27 2004-06-17 Диетическая композиция, содержащая вазопротекторные агенты
CA2530660A CA2530660C (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
BRPI0411811-1A BRPI0411811B1 (pt) 2003-06-27 2004-06-17 Composições farmacêuticas, dietéticas ou nutricionais e emprego de uma combinação de agentes vasoprotetores na preparação de composições hipocolesterolemizantes
EP04739969.6A EP1638417B1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
PL04739969T PL1638417T3 (pl) 2003-06-27 2004-06-17 Kombinacje środków chroniących naczynia i kompozycje zawierające te kombinacje
NZ544399A NZ544399A (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
TR2019/00241T TR201900241T4 (tr) 2003-06-27 2004-06-17 Vasoprotektif maddelerin kombinasyonları ve bunları içeren formülasyonlar.
AU2004251009A AU2004251009B2 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
JP2006515963A JP4960087B2 (ja) 2003-06-27 2004-06-17 血管保護物質の組合せおよびそれらを含む製剤
PT04739969T PT1638417T (pt) 2003-06-27 2004-06-17 Combinações de agentes vasoprotetores e formulações que os contêm
KR1020057024537A KR101165934B1 (ko) 2003-06-27 2004-06-17 혈관보호제들의 합제와 그들을 함유한 제제
DK04739969.6T DK1638417T3 (en) 2003-06-27 2004-06-17 COMBINATIONS OF VASO PROTECTIVE AGENTS AND FORMS CONTAINING THESE
US10/562,214 US20090036520A1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
PCT/EP2004/006507 WO2005000041A1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
MXPA05013625A MXPA05013625A (es) 2003-06-27 2004-06-17 Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos.
HK06111347.1A HK1090519B (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
HUE04739969A HUE042048T2 (hu) 2003-06-27 2004-06-17 Vazoprotektív szerek kombinációi és ezeket tartalmazó készítmények
ES04739969T ES2704633T3 (es) 2003-06-27 2004-06-17 Combinaciones de agentes vasoprotectores y formulaciones que los contienen
NO20056162A NO330523B1 (no) 2003-06-27 2005-12-23 Kombinasjoner av vasobeskyttende agenser og formuleringer inneholdende dem og anvendelse derav
RU2009109089/13A RU2489907C2 (ru) 2003-06-27 2009-03-12 Комбинации вазопротекторных агентов и препаративные формы, содержащие такие комбинации
US12/721,015 US20100160427A1 (en) 2003-06-27 2010-03-10 Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents
US13/033,826 US8206759B2 (en) 2003-06-27 2011-02-24 Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.

Publications (2)

Publication Number Publication Date
ITMI20031313A0 true ITMI20031313A0 (it) 2003-06-27
ITMI20031313A1 ITMI20031313A1 (it) 2004-12-28

Family

ID=30131309

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.

Country Status (21)

Country Link
US (3) US20090036520A1 (it)
EP (1) EP1638417B1 (it)
JP (1) JP4960087B2 (it)
KR (1) KR101165934B1 (it)
CN (1) CN100475061C (it)
AU (1) AU2004251009B2 (it)
BR (1) BRPI0411811B1 (it)
CA (1) CA2530660C (it)
DK (1) DK1638417T3 (it)
ES (1) ES2704633T3 (it)
HU (1) HUE042048T2 (it)
IT (1) ITMI20031313A1 (it)
MX (1) MXPA05013625A (it)
NO (1) NO330523B1 (it)
NZ (1) NZ544399A (it)
PL (1) PL1638417T3 (it)
PT (1) PT1638417T (it)
RU (2) RU2361430C2 (it)
SI (1) SI1638417T1 (it)
TR (1) TR201900241T4 (it)
WO (1) WO2005000041A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017153B2 (en) 2006-02-07 2011-09-13 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
US8202541B2 (en) * 2006-02-07 2012-06-19 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
JP4469406B1 (ja) * 2009-06-30 2010-05-26 株式会社ファンケル 血中コレステロール低下剤
JP4469407B1 (ja) * 2009-06-30 2010-05-26 株式会社ファンケル 血中中性脂肪低下剤
KR101294970B1 (ko) * 2011-06-30 2013-08-09 고려대학교 산학협력단 폴리코사놀 에스터, 이의 제조 방법 및 이를 포함하는 첨가제
KR101700949B1 (ko) * 2013-03-15 2017-01-31 나놀스, 인코포레이티드 메타디콜(등록상표) 액체 및 겔 나노입자 제형
EP3902399A1 (en) 2018-12-27 2021-11-03 3M Innovative Properties Company Antimicrobial compositions with 1,2-alkanediols
IT201900020808A1 (it) * 2019-11-11 2021-05-11 Neilos S R L Composizione per la riduzione del rischio cardiovascolare

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
JP3142245B2 (ja) * 1996-06-28 2001-03-07 株式会社資生堂 皮膚外用剤
IT1283143B1 (it) * 1996-07-12 1998-04-07 Indena Spa Metodo di estrazione del licopene ed estratti che lo contengono
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
AU9209898A (en) * 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
KR20000019717A (ko) * 1998-09-15 2000-04-15 박호군 루틴 및 쿼세틴을 포함하는 고지혈증, 동맥경화증 및 간 질환의예방 및 치료용 조성물
FR2792831B1 (fr) * 1999-04-28 2001-08-03 Bionatec Sarl Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier
KR100319397B1 (ko) 1999-07-12 2002-01-05 남 승 우 천연식물소재 추출물을 이용한 항혈전 및 고지혈증 억제 조성물
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US20020120001A1 (en) * 2000-10-13 2002-08-29 Ashni Naturaceuticals, Inc. Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e

Also Published As

Publication number Publication date
NZ544399A (en) 2009-04-30
RU2361430C2 (ru) 2009-07-20
CN100475061C (zh) 2009-04-08
JP4960087B2 (ja) 2012-06-27
WO2005000041A1 (en) 2005-01-06
AU2004251009B2 (en) 2010-06-17
ES2704633T3 (es) 2019-03-19
US20110142967A1 (en) 2011-06-16
DK1638417T3 (en) 2019-01-28
RU2009109089A (ru) 2010-09-20
KR20060072098A (ko) 2006-06-27
US20090036520A1 (en) 2009-02-05
EP1638417A1 (en) 2006-03-29
NO20056162L (no) 2005-12-23
AU2004251009A1 (en) 2005-01-06
RU2489907C2 (ru) 2013-08-20
HK1090519A1 (zh) 2006-12-29
PT1638417T (pt) 2019-01-17
RU2005140574A (ru) 2006-05-10
US8206759B2 (en) 2012-06-26
ITMI20031313A1 (it) 2004-12-28
BRPI0411811B1 (pt) 2018-05-29
CA2530660C (en) 2013-08-20
EP1638417B1 (en) 2018-10-10
JP2007519603A (ja) 2007-07-19
CN1812729A (zh) 2006-08-02
MXPA05013625A (es) 2006-02-24
NO330523B1 (no) 2011-05-09
HUE042048T2 (hu) 2019-06-28
SI1638417T1 (sl) 2019-02-28
US20100160427A1 (en) 2010-06-24
PL1638417T3 (pl) 2019-03-29
BRPI0411811A (pt) 2006-08-08
TR201900241T4 (tr) 2019-02-21
KR101165934B1 (ko) 2012-07-19
CA2530660A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
EP1653970A4 (en) GSK-3 HEMMER AND ITS USES
NO2017017I1 (no) umeklinidium og vilanterol
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DE602004031564D1 (de) Personenbezogene identifikationseinrichtung
DK1809622T3 (da) Inhibitorer af interaktionen mellem MDM2 og P53
CY2014001I1 (el) Συνδυασμος αζελαστινης και φλουτικαζονης
NO20054453D0 (no) P38 inhibitorer og fremgangsmater for anvendelse derav
EP1602861A4 (en) BUMPER FOR TRANSMISSION
DK2277976T3 (da) Sammensætninger omfattende hfc-1234ze og smøremiddel
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
ATE354631T1 (de) Nuancierungsmittel
FI20045376A0 (fi) Kanta-asiakaskortti ja siihen liittyviä laitteita
EP1701725A4 (en) PROCESS AND COMPOSITIONS
DE602004018837D1 (de) Ptidase-iv-inhibitoren
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
ATE423117T1 (de) Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone
PT1558595E (pt) Piperazinil e diazepanil benzamidas e benzotioamidas
DE602004013477D1 (de) Metallische Keilriemen
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf
DE502004006055D1 (de) 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren
EP1898915A4 (en) COMBINATIONS OF ESZOPICLON AND ANTIDEPRESSIVE
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
ITMI20031313A0 (it) Associazione di agenti vasoprotettori e formazioni che li contengono
IS8399A (is) Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns